SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-11
👔
Hemab Therapeutics Holdings, Inc.
@COAG_InsiderForm 4 Filing: Shah Rajeev M. Buys $1.3M of $COAG
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Hemab Therapeutics Holdings, Inc.
Ticker: $COAG
Transaction Value
$1.3M
Price/Share: $24.75
transaction date
2026-05-11
Shares: 51,258
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shah Rajeev M., holds the title of 10% Owner at Hemab Therapeutics Holdings, Inc..
On 2026-05-11, the insider transacted 51,258 shares.The shares were transacted at a weighted average price of $24.75 per share, resulting in a total market-relevant value of $1.3M.
Executive Summary Summary
Shah Rajeev M. (10% Owner) bought $1.3M of $COAG
Post-Transaction Position: 6,365,783 shares
SEC Accession No: 0001231919-26-000475 (CIK: 1619841)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.